What is Insulin Potentiation Therapy Low Dose (IPTLD™)?

Why is IPTLD™ needed?

Over time regular chemotherapy dosages may so compromise the patient's blood counts, immune system and organ function as to preclude further treatment or even cause organ damage resulting in the patient's death. IPTLD™ eliminates the "lesser of two evils" decision all cancer patients face when diagnosed. Patients thrive as they experience a gentle and effective answer to cancer.

What are the dangers of regular chemotherapy?

Cancer cells are voracious in fighting for the life-sustaining glucose found in the blood stream. With 16 times the number of insulin receptors of a healthy cell, cancer cells steal any and all essential nutrients from goods cells. This is why, in advanced stages of this disease, a tumor continues to grow while the patient becomes emaciated and simply wastes away. Added to this, because of membrane protection from toxins, standard administered chemotherapy must be in large enough quantities to force penetration of cell walls. This results in the indiscriminate penetration and killing of both healthy and cancerous cells as well as most frequently leaving the patient with fever, nausea, vomiting, hair loss, diminished quality of life.

How Does IPTLD™ work?

IPT LD™ uses insulin to stimulate division in cancer cells. Chemotherapy penetrates better when cells are dividing. Because of this targeted action IPTLD™ uses only 10 - 15% of standard dose drugs and the procedure affects only the cancer while leaving normal cells strong and healthy. This means that patients continue to thrive, maintain their lifestyle, and be vital while the cancer is eradicated.

What are the benefits of IPTLD™?

• IPTLD™ can be very tough against tumors while being very gentle for the patient who continues to live a normal, vital lifestyle while being treated.
• If there is a chemotherapy drug that works against a particular type of tumor, it is likely to work better with IPTLD™
• Gentle treatment often precludes the need for surgery or radiation.
• Treatments costs are significantly less than standard procedure.

What cancers respond to IPTLD™?

IPTLD™ has been reported to work especially well for breast, prostate, lung, colon, stomach cancers, lymphoma, and melanoma. There are also reports of IPTLD™ bringing responses and remissions to patients with some very difficult cancers, including pancreatic, ovarian, and renal cell cancers. Other cancers successfully treated are blood, bone, cervical, esophageal, lip, mouth, neck, small intestines, testicular, throat, thyroid, uterine and vaginal.